Abandoning apoptosis in favor of selective differentiation has proven a fruitful strategy in the search for AML treatments.
A maternal-fetal medicine expert answers six vital questions about balancing cancer and pregnancy care, revealing the benefits of a team-based approach.
A new study shows that physicians may be overtreating patients with well-differentiated thyroid cancer and putting them at risk for more deadly diseases.
Early trial data show that precision therapy enasidenib can induce durable complete remission in patients with relapsed/refractory acute myeloid leukemia.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Several promising antibody-based treatment strategies are in development for acute lymphoblastic leukemia and acute myeloid leukemia. These could change the decade-old treatment paradigm.